Abstract
Prevalence, serotype and in vitro secretion of aspartyl proteinase, a virulence enzyme, were studied in Candida isolates from the oral cavity of 337 HIV-infected subjects. Controls were 95 age-sex-matched HIV- (seronegative) subjects, belonging to either HIV-risk categories (47) or to the normal, general population (48). Fungi were isolated from 155 HIV+ subjects. C. albicans was the most prevalent species (85.8% of all isolates). 94.6% of C. albicans isolates were serotype A and all were agglutinated by a monoclonal antibody (AF1) directed against a major mannoprotein immunogen of the candidal cell wall, confirming previous results with C. albicans isolates from non-immunodeficient subjects. With regard to the stage of HIV infection, there were no statistically significant differences in the incidence of oral Candida carriage between asymptomatic (stage II) HIV+ and HIV- subjects, and between stage II and lymphadenopathic (stage III) individuals. Also, the low (3.8%) incidence of oral candidiasis in the subjects of the latter stage was insignificant with respect to stage II subjects. However, the incidence of C. albicans in stage IV (AIDS) subjects (46.8%) was significantly higher than in all other subjects, and in almost all cases, fungal isolation was accompanied by oral thrush and lower CD4+ lymphocyte counts (< 400 × 10°/L).
All isolates of C. albicans were proteolytic in vitro, as assessed by scoring the proteinase activity on BSA agar and monitoring the secreted proteinase antigen by a highly sensitive (1 ng) and specific immunoenzymatic assay. However, by both methods, the isolates from subjects at stages III and IV of infection produced more secretory proteinase than the isolates from either HIV+ asymptomatic subjects or HIV- controls. The differences could not be attributed to particular culture media or source of Candida isolation (carriage versus active infection). Thus, the isolates of C. albicans from advanced HIV infection are serologically similar but more proteolytic than the isolates from earlier stages of HIV infection or those from HIV-uninfected subjects. The apparently higher virulence of C. albicans from AIDS subjects may represent a co-factor in determining and/or aggravating oral candidiasis in these patients.
Similar content being viewed by others
References
AgatensiL., FranchiF., MondelloF., BevilacquaR.L., CeddiaT., DeBernardisF. and CassoneA. (1991): Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic - J. Clin. Pathol. 44: 826–830.
AngiolellaL., DeBernardisF., BromuroC., MondelloF., CeddiaT. and CassoneA. (1990): The effects of antimycotics on secretory acid proteinase of Candida albicans - J. Chemoter 5: 1–7.
BrawnerD.L. and CutlerJ.E. (1989): Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients and immunocompromised patients with or without acquired immunodeficiency syndrome - J. Clin. Microbiol. 27: 1335–1341.
Brawner D.L. (1991): Serotyping approaches to Candida albicans strain differentiation. XI ISHAM Congress Montreal - Canada Abstract S10.2 pag. 33.
CantornaM.B. and BalishE. (1990): Mucosal and systemic candidiasis in congenitally immunodeficient mice - Infect. Immun. 58: 1093–1100.
CassoneA., DeBernardisF., MondelloF., CeddiaT. and AgatensiL. (1987): Evidence for a correlation between proteinase secretion and vulvovaginal candidosis - J. Infect. Dis. 156: 777–783.
CassoneA., TorosantucciA., BoccaneraM., PellegriniG., PalmaC. and MalavasiF. (1988): Production and characterization of a monoclonal antibody to a cell surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species - J. Med. Microbiol. 27: 233–238.
CenciE., RomaniL., VecchiarelliA., PuccettiP. and BistoniF. (1989): Role of L3T4 lymphocytes in protective immunity to systemic Candida albicans infection in mice - Infect. Immun. 57: 3581–3587.
DeBernardisA., AgatensiL., RossI.K., EmersonG.W., LorenziniR., SullivanA. and CassoneA. (1990): Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidosis - J. Infect. Dis. 161: 1276–1283.
HolmbergK. and MeyerR.D. (1986): Fungal infections in patients with AIDS and AIDS-related complex -Scand. J. Infect. Dis. 18: 179–185.
KleinR.S., HarrisC.A., Butkus SmallC., MollB., LesserM. and FriedlandG.H. (1984): Oral candidiasis in high risk patients as the initial manifestation of the acquired immunodefciency syndrome - N. Engl. J. Med. 311: 354–357.
ImanN., CarpenterecJ., KennethH.M., FisherA., SteinM. and DanforthS.B. (1990): Hierarchical pattern of mucosal candidal infection in HIV-seropositive women - Am. J. Med. 89: 142–146.
Mendes-Giannini M.J.S., Melhem MS.C, Giudice M.C., Moraes R.A., Toscano E., Branco F.C, Carvalho R.X. and Ricci T.A. (1991): Candida albicans in patients with the acquired immunodeficiency syndrome - XI ISHAM Congress Montreal - Canada- Abstract PS 2.14 pag. 93.
Meyer S.A., Ahearn G. and Yarrow D. (1984): Genus 4 Candida Berkhout. In: Kreger NJW (ed) The yeasts, a taxonomic study - Amsterdam Elsevier Science Publishing Inc. 764–767.
MondelloF., GuglielminettiM., TorosantucciA., CeddiaT., AgatensiL. and CassoneA. (1986): Yeast species isolated from outpatients with vulvovaginal candidosis attending a gynecological center in Rome- IRCS Med. Sci. 14: 746–747.
Odds F.C. (1988): Candida and candidosis - Leicester University Press.
QuintiI., PalmaC., GuerraE.C., GomezM.J., MezzaromaI., AiutiF. and CassoneA. (1991): Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects - Clin. Exp. Immunol. 85: 485–492.
RossI.K., DeBernardisF., EmersonG.W., CassoneA. and Sulliv nP.A. (1990): The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutant - J. Gen. Microbiol. 136: 687–694.
RuchelR., DeBernardisF., RayT.L., SullivanP.A. and ColeG.T. (1982): Candida acid proteinases - J. Med. Vet. Mycology 29: supplement 1–9.
TorosantucciA., BoccaneraM., CasalinuovoI., PellegriniG. and CassoneA. (1990a): Differences in the antigenic expression of immunomodulatory mannoprotein constituents on yeast and mycelial forms of Candida albicans - J. Gen. Microbiol. 136: 1421–1428.
TorosantucciA., PalmaC., BoccaneraM., AusielloCM., SpagnoliG.C. and CassoneA. (1990b): Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans - J. Gen. Microbiol. 136: 2155–2163.
TsuchiyaT., TaguchiM., FukazawaY. and ShinodaT. (1984): Serological characterization p. 75–26. In T. Bergan (ed) Methods in microbiology vol. 16 Academic Press Inc. (London) LTd. London.
WhelanW.L., KirschD.R., Kwon-Chung, WahlS.M. and SmithP.D. (1990): Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel or hypervirulent strain - J. Infect. Dis. 162: 513–518.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Bernardis, F., Boccanera, M., Rainaldi, L. et al. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects. Eur J Epidemiol 8, 362–367 (1992). https://doi.org/10.1007/BF00158569
Issue Date:
DOI: https://doi.org/10.1007/BF00158569